Skip to main
AUPH
AUPH logo

Aurinia Pharmaceuticals (AUPH) Market Capitalization Overview

Market Cap: $1.02B as of Jul 2, 2025

$1.02B
Past Month-$63.50M (5.90%)
As of Jul 2, 2025, Aurinia Pharmaceuticals (AUPH) has a market capitalization of $1.02B. Over the past 30 days, its market cap has decreased by -6.03%, while in the last 12 months, it has decreased by -21.3%.

Market capitalization represents the total value of Aurinia Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Aurinia Pharmaceuticals (AUPH) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Aurinia Pharmaceuticals (AUPH) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Aurinia Pharmaceuticals (AUPH) Market Cap History

DateMarket CapChange
Jul 1, 2025$1.02B-6.03%
Jun 2, 2025$1.08B-4.02%
May 1, 2025$1.13B+1.35%
Apr 1, 2025$1.11B+0.88%
Mar 3, 2025$1.10B-1.99%
Feb 3, 2025$1.12B-10.95%
Jan 2, 2025$1.26B-3.63%

Aurinia Pharmaceuticals (AUPH) End of Year Market Cap History

DateMarket CapChange
2025$1.02B-21.30%
2024$1.29B-0.41%
2023$1.30B+110.30%
2022$613.92M-79.30%
2021$2.97B+69.42%
2020$1.76B

FAQs About Aurinia Pharmaceuticals (AUPH) Market Cap

As of Jul 2, 2025, the market capitalization of Aurinia Pharmaceuticals (AUPH) is $1.02B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Aurinia Pharmaceuticals’s market capitalization has decreased by -5.90%, changing from $1.08B to $1.02B as of Jul 2, 2025.

In the last 3 months, Aurinia Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Aurinia Pharmaceuticals’s market capitalization decreased from $1.30B in January to $1.29B in December, reflecting a -0.41% change.

In the past five years, Aurinia Pharmaceuticals (AUPH) has had a compound annual growth rate (CAGR) of -5.98% in market capitalization. This means its market cap has shrunk at an average rate of -5.98% per year.

Aurinia Pharmaceuticals (AUPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.